Canopy Growth's revenue and EBITDA have been disappointing, and analysts' projections for FY25 and FY26 remain weak. Read why ...

It has experienced a hiccup, but the company is still on the right path. That’s the opinion of Roth MKM analyst Bill Kirk on ...

Canopy Growth Corporation (CGC) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's ...

In a report released on November 8, Lisa Lewandowski from Bank of America Securities reiterated a Sell rating on Canopy Growth (CGC – Research Report), with a price target of C$ ... dampen investor ...

Analysts estimate that Canopy Growth will report an earnings per share (EPS) of $-0.32. The announcement from Canopy Growth is eagerly anticipated, with investors seeking news of surpassing estimates ...

The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.

Aurora's international medical cannabis business bolstered its results, with European sales doubling quarter-over-quarter.

My name is Nicole, and I will be your conference operator today. I would like to welcome you to Canopy Growth's second ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...